While BCL6 expression and phenotypic reversion may provide an explanation for observations in advanced myeloma, and myeloma cell lines, it is important to distinguish between such transformed states and those operating in normal plasma cells, and early plasma cell neoplasms. Here, BCL6 is linked to plasma cell myeloma.